SUPERNUS PHARMACEUTICALS, INC. Diluted Shares Outstanding (Weighted Average)
SUPERNUS PHARMACEUTICALS, INC. (SUPN) reported Diluted Shares Outstanding (Weighted Average) of 58.07 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-08-03
- SUPERNUS PHARMACEUTICALS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 58.07M shares, a 2.52% increase year-over-year.
- SUPERNUS PHARMACEUTICALS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 57.65M shares, a 3.19% increase year-over-year.
- SUPERNUS PHARMACEUTICALS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was 57.40M shares, a 1.67% increase year-over-year.
- SUPERNUS PHARMACEUTICALS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 56.55M shares, a 0.96% increase year-over-year.
- SUPERNUS PHARMACEUTICALS, INC. weighted average number of shares outstanding, diluted for fiscal 2025 was 56.45M shares, a 0.88% increase from fiscal 2024.
- SUPERNUS PHARMACEUTICALS, INC. weighted average number of shares outstanding, diluted for fiscal 2024 was 55.96M shares, a 0.81% increase from fiscal 2023.
- SUPERNUS PHARMACEUTICALS, INC. weighted average number of shares outstanding, diluted for fiscal 2023 was 55.51M shares, a 10.01% decline from fiscal 2022.
- SUPERNUS PHARMACEUTICALS, INC. weighted average number of shares outstanding, diluted for fiscal 2022 was 61.68M shares, a 13.47% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 9 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 12 month | Weighted Average Number of Shares Outstanding, Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | 58.07M shares 10-Q · filed 2026-08-03 | 57.86M shares 10-Q · filed 2026-08-03 | 57.71M shares derived: average of 3 quarters · filed 2026-08-03 | 57.42M shares derived: average of 4 quarters · filed 2026-08-03 | |||
| 2026-03-31 | 57.65M shares 10-Q · filed 2026-05-05 | 57.53M shares derived: average of 2 quarters · filed 2026-05-05 | 57.20M shares derived: average of 3 quarters · filed 2026-05-05 | 57.06M shares derived: average of 4 quarters · filed 2026-08-03 | |||
| 2025-12-31 | 57.40M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | 56.98M shares derived: average of 2 quarters · filed 2026-03-02 | 56.87M shares derived: average of 3 quarters · filed 2026-08-03 | 56.45M shares 10-K · filed 2026-03-02 | |||
| 2025-09-30 | 56.55M shares 10-Q · filed 2025-11-06 | 56.60M shares derived: average of 2 quarters · filed 2026-08-03 | 56.13M shares 10-Q · filed 2025-11-06 | 56.38M shares derived: average of 4 quarters · filed 2026-08-03 | |||
| 2025-06-30 | 56.64M shares 10-Q · filed 2026-08-03 | 56.69M shares 10-Q · filed 2026-08-03 | 56.32M shares derived: average of 3 quarters · filed 2026-08-03 | 56.25M shares derived: average of 4 quarters · filed 2026-08-03 | |||
| 2025-03-31 | 55.86M shares 10-Q · filed 2026-05-05 | 56.16M shares derived: average of 2 quarters · filed 2026-05-05 | 56.11M shares derived: average of 3 quarters · filed 2026-05-05 | 56.02M shares derived: average of 4 quarters · filed 2026-05-05 | |||
| 2024-12-31 | 56.46M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | 56.24M shares derived: average of 2 quarters · filed 2026-03-02 | 56.07M shares derived: average of 3 quarters · filed 2026-03-02 | 55.96M shares 10-K · filed 2026-03-02 | |||
| 2024-09-30 | 56.02M shares 10-Q · filed 2025-11-06 | 55.87M shares derived: average of 2 quarters · filed 2025-11-06 | 55.79M shares 10-Q · filed 2025-11-06 | 55.67M shares derived: average of 4 quarters · filed 2026-03-02 | |||
| 2024-06-30 | 55.72M shares 10-Q · filed 2025-08-05 | 55.68M shares 10-Q · filed 2025-08-05 | 55.55M shares derived: average of 3 quarters · filed 2026-03-02 | 55.32M shares derived: average of 4 quarters · filed 2026-03-02 | |||
| 2024-03-31 | 55.63M shares 10-Q · filed 2025-05-06 | 55.46M shares derived: average of 2 quarters · filed 2026-03-02 | 55.18M shares derived: average of 3 quarters · filed 2026-03-02 | 55.01M shares derived: average of 4 quarters · filed 2026-03-02 | |||
| 2023-12-31 | 55.30M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | 54.96M shares derived: average of 2 quarters · filed 2026-03-02 | 54.80M shares derived: average of 3 quarters · filed 2026-03-02 | 55.51M shares 10-K · filed 2026-03-02 | |||
| 2023-09-30 | 54.61M shares 10-Q · filed 2024-11-04 | 54.56M shares derived: average of 2 quarters · filed 2024-11-04 | 55.57M shares 10-Q · filed 2024-11-04 | 58.41M shares derived: average of 4 quarters · filed 2025-02-25 | |||
| 2023-06-30 | 54.50M shares 10-Q · filed 2024-08-06 | 59.04M shares 10-Q · filed 2024-08-06 | 59.68M shares derived: average of 3 quarters · filed 2025-02-25 | 58.52M shares derived: average of 4 quarters · filed 2025-02-25 | |||
| 2023-03-31 | 62.45M shares 10-Q · filed 2024-05-08 | 62.27M shares derived: average of 2 quarters · filed 2025-02-25 | 59.86M shares derived: average of 3 quarters · filed 2025-02-25 | 60.24M shares derived: average of 4 quarters · filed 2025-02-25 | |||
| 2022-12-31 | 62.09M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | 58.56M shares derived: average of 2 quarters · filed 2025-02-25 | 59.51M shares derived: average of 3 quarters · filed 2025-02-25 | 61.68M shares 10-K · filed 2025-02-25 | |||
| 2022-09-30 | 55.03M shares 10-Q · filed 2023-11-08 | 58.22M shares derived: average of 2 quarters · filed 2023-11-08 | 61.54M shares 10-Q · filed 2023-11-08 | 58.09M shares derived: average of 4 quarters · filed 2023-11-08 | |||
| 2022-06-30 | 61.40M shares 10-Q · filed 2023-08-08 | 61.40M shares 10-Q · filed 2023-08-08 | 59.11M shares derived: average of 3 quarters · filed 2023-08-08 | 57.92M shares derived: average of 4 quarters · filed 2023-08-08 | |||
| 2022-03-31 | 61.41M shares 10-Q · filed 2023-05-09 | 57.96M shares derived: average of 2 quarters · filed 2023-05-09 | 56.75M shares derived: average of 3 quarters · filed 2023-05-09 | 56.25M shares derived: average of 4 quarters · filed 2023-05-09 | |||
| 2021-12-31 | 54.52M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | 54.43M shares derived: average of 2 quarters · filed 2023-03-09 | 54.53M shares derived: average of 3 quarters · filed 2023-03-09 | 54.36M shares 10-K · filed 2023-03-09 | |||
| 2021-09-30 | 54.33M shares 10-Q · filed 2022-11-09 | 54.53M shares derived: average of 2 quarters · filed 2022-11-09 | 54.30M shares 10-Q · filed 2022-11-09 | 54.26M shares derived: average of 4 quarters · filed 2023-03-09 | |||
| 2021-06-30 | 54.72M shares 10-Q · filed 2022-08-08 | 54.60M shares 10-Q · filed 2022-08-08 | 54.23M shares derived: average of 3 quarters · filed 2023-03-09 | 54.11M shares derived: average of 4 quarters · filed 2023-03-09 | |||
| 2021-03-31 | 54.20M shares 10-Q · filed 2022-05-12 | 53.98M shares derived: average of 2 quarters · filed 2023-03-09 | 53.91M shares derived: average of 3 quarters · filed 2023-03-09 | 53.84M shares derived: average of 4 quarters · filed 2023-03-09 | |||
| 2020-12-31 | 53.77M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | 53.77M shares derived: average of 2 quarters · filed 2023-03-09 | 53.73M shares derived: average of 3 quarters · filed 2023-03-09 | 53.69M shares 10-K · filed 2023-03-09 | |||
| 2020-09-30 | 53.76M shares 10-Q · filed 2021-11-05 | 53.70M shares derived: average of 2 quarters · filed 2021-11-05 | 53.66M shares 10-Q · filed 2021-11-05 | 53.64M shares derived: average of 4 quarters · filed 2022-04-13 | |||
| 2020-06-30 | 53.65M shares 10-Q · filed 2021-08-06 | 53.61M shares 10-Q · filed 2021-08-06 | 53.60M shares derived: average of 3 quarters · filed 2022-04-13 | 53.65M shares derived: average of 4 quarters · filed 2022-04-13 | |||
| 2020-03-31 | 53.58M shares 10-Q · filed 2021-05-07 | 53.58M shares derived: average of 2 quarters · filed 2022-04-13 | 53.65M shares derived: average of 3 quarters · filed 2022-04-13 | 53.72M shares derived: average of 4 quarters · filed 2022-04-13 | |||
| 2019-12-31 | 53.57M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-13 | 53.69M shares derived: average of 2 quarters · filed 2022-04-13 | 53.76M shares derived: average of 3 quarters · filed 2022-04-13 | 53.82M shares 10-K · filed 2022-04-13 | |||
| 2019-09-30 | 53.81M shares 10-Q · filed 2020-11-06 | 53.86M shares derived: average of 2 quarters · filed 2020-11-06 | 53.90M shares 10-Q · filed 2020-11-06 | 53.95M shares derived: average of 4 quarters · filed 2021-03-08 | |||
| 2019-06-30 | 53.91M shares 10-Q · filed 2020-08-17 | 53.95M shares 10-Q · filed 2020-08-17 | 54.00M shares derived: average of 3 quarters · filed 2021-03-08 | 54.06M shares derived: average of 4 quarters · filed 2021-03-08 | |||
| 2019-03-31 | 53.99M shares 10-Q · filed 2020-05-15 | 54.04M shares derived: average of 2 quarters · filed 2021-03-08 | 54.11M shares derived: average of 3 quarters · filed 2021-03-08 | 54.13M shares derived: average of 4 quarters · filed 2021-03-08 | |||
| 2018-12-31 | 54.10M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-08 | 54.17M shares derived: average of 2 quarters · filed 2021-03-08 | 54.18M shares derived: average of 3 quarters · filed 2021-03-08 | 54.10M shares 10-K · filed 2021-03-08 | |||
| 2018-09-30 | 54.24M shares 10-Q · filed 2019-11-08 | 54.22M shares derived: average of 2 quarters · filed 2019-11-08 | 54.10M shares 10-Q · filed 2019-11-08 | 53.94M shares derived: average of 4 quarters · filed 2020-02-28 | |||
| 2018-06-30 | 54.20M shares 10-Q · filed 2019-08-09 | 54.02M shares 10-Q · filed 2019-08-09 | 53.84M shares derived: average of 3 quarters · filed 2020-02-28 | 53.79M shares derived: average of 4 quarters · filed 2020-02-28 | |||
| 2018-03-31 | 53.79M shares 10-Q · filed 2019-05-10 | 53.66M shares derived: average of 2 quarters · filed 2020-02-28 | 53.65M shares derived: average of 3 quarters · filed 2020-02-28 | 53.54M shares derived: average of 4 quarters · filed 2020-02-28 | |||
| 2017-12-31 | 53.52M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | 53.58M shares derived: average of 2 quarters · filed 2020-02-28 | 53.46M shares derived: average of 3 quarters · filed 2020-02-28 | 53.30M shares 10-K · filed 2020-02-28 | |||
| 2017-09-30 | 53.63M shares 10-Q · filed 2018-11-09 | 53.43M shares derived: average of 2 quarters · filed 2018-11-09 | 53.23M shares 10-Q · filed 2018-11-09 | 52.90M shares derived: average of 4 quarters · filed 2019-03-01 | |||
| 2017-06-30 | 53.22M shares 10-Q · filed 2018-08-09 | 53.03M shares 10-Q · filed 2018-08-09 | 52.66M shares derived: average of 3 quarters · filed 2019-03-01 | 52.49M shares derived: average of 4 quarters · filed 2019-03-01 | |||
| 2017-03-31 | 52.76M shares 10-Q · filed 2018-05-10 | 52.38M shares derived: average of 2 quarters · filed 2019-03-01 | 52.24M shares derived: average of 3 quarters · filed 2019-03-01 | 52.12M shares derived: average of 4 quarters · filed 2019-03-01 | |||
| 2016-12-31 | 51.99M shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | 51.98M shares derived: average of 2 quarters · filed 2019-03-01 | 51.90M shares derived: average of 3 quarters · filed 2019-03-01 | 51.71M shares 10-K · filed 2019-03-01 | |||
| 2016-09-30 | 51.97M shares 10-Q · filed 2017-11-09 | 51.86M shares derived: average of 2 quarters · filed 2017-11-09 | 51.62M shares 10-Q · filed 2017-11-09 | 51.58M shares derived: average of 4 quarters · filed 2018-03-01 | |||
| 2016-06-30 | 51.75M shares 10-Q · filed 2017-08-03 | 51.48M shares 10-Q · filed 2017-08-03 | 51.45M shares derived: average of 3 quarters · filed 2018-03-01 | 51.49M shares derived: average of 4 quarters · filed 2018-03-01 | |||
| 2016-03-31 | 51.15M shares 10-Q · filed 2017-05-09 | 51.31M shares derived: average of 2 quarters · filed 2018-03-01 | 51.40M shares derived: average of 3 quarters · filed 2018-03-01 | 51.62M shares derived: average of 4 quarters · filed 2018-03-01 | |||
| 2015-12-31 | 51.46M shares derived: 10-K 12 month − 10-Q/A 9 month · filed 2018-03-01 | 51.53M shares derived: average of 2 quarters · filed 2018-03-01 | 51.78M shares derived: average of 3 quarters · filed 2018-03-01 | 51.16M shares 10-K · filed 2018-03-01 | |||
| 2015-09-30 | 51.59M shares 10-Q/A · filed 2017-01-20 | 51.93M shares derived: average of 2 quarters · filed 2017-01-23 | 51.06M shares 10-Q/A · filed 2017-01-20 | 47.93M shares derived: average of 4 quarters · filed 2017-03-16 | |||
| 2015-06-30 | 52.27M shares 10-Q/A · filed 2017-01-23 | 47.69M shares 10-Q/A · filed 2017-01-23 | 46.70M shares derived: average of 3 quarters · filed 2017-03-16 | 45.75M shares derived: average of 4 quarters · filed 2017-03-16 | |||
| 2015-03-31 | 44.90M shares 10-Q/A · filed 2017-01-20 | 43.92M shares derived: average of 2 quarters · filed 2017-03-16 | 43.58M shares derived: average of 3 quarters · filed 2017-03-16 | 43.28M shares derived: average of 4 quarters · filed 2017-03-16 | |||
| 2014-12-31 | 42.94M shares derived: 10-K 12 month − 10-Q/A 9 month · filed 2017-03-16 | 42.92M shares derived: average of 2 quarters · filed 2017-03-16 | 42.74M shares derived: average of 3 quarters · filed 2017-03-16 | 42.26M shares 10-K · filed 2017-03-16 | 50.58M shares 10-K · filed 2015-03-12 | ||
| 2014-09-30 | 42.90M shares 10-Q/A · filed 2017-01-20 | 50.83M shares 10-Q · filed 2014-11-12 | 42.64M shares derived: average of 2 quarters · filed 2017-01-20 | 42.04M shares 10-Q/A · filed 2017-01-20 | 50.38M shares 10-Q · filed 2014-11-12 | 40.27M shares derived: average of 4 quarters · filed 2017-01-20 | |
| 2014-06-30 | 42.37M shares 10-Q · filed 2015-08-07 | 41.60M shares 10-Q · filed 2015-08-07 | 39.39M shares derived: average of 3 quarters · filed 2017-01-20 | 37.28M shares derived: average of 4 quarters · filed 2017-01-20 | |||
| 2014-03-31 | 41.13M shares 10-Q · filed 2015-05-06 | 37.90M shares derived: average of 2 quarters · filed 2017-01-20 | 35.58M shares derived: average of 3 quarters · filed 2017-01-20 | 34.41M shares derived: average of 4 quarters · filed 2017-01-20 | |||
| 2013-12-31 | 34.68M shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2017-01-20 | 32.81M shares derived: average of 2 quarters · filed 2017-01-20 | 32.17M shares derived: average of 3 quarters · filed 2017-01-20 | 31.85M shares 10-K/A · filed 2017-01-20 | |||
| 2013-09-30 | 30.94M shares 10-Q · filed 2014-11-12 | 30.92M shares derived: average of 2 quarters · filed 2014-11-12 | 30.90M shares 10-Q · filed 2014-11-12 | ||||
| 2013-06-30 | 30.90M shares 10-Q · filed 2014-08-12 | 30.89M shares 10-Q · filed 2014-08-12 | |||||
| 2012-12-31 | 17.44M shares 10-K · filed 2015-03-12 | ||||||
| 2012-06-30 | 16.82M shares 10-Q · filed 2012-08-13 | 9.25M shares 10-Q · filed 2012-08-13 | |||||
| 2012-03-31 | 1.68M shares 10-Q · filed 2012-06-08 | ||||||
| 2011-12-31 | 1.61M shares 10-K · filed 2013-03-15 | ||||||
| 2011-06-30 | 1.59M shares 10-Q · filed 2012-08-13 | 1.59M shares 10-Q · filed 2012-08-13 | |||||
| 2011-03-31 | 1.59M shares 10-Q · filed 2012-06-08 | ||||||
| 2010-12-31 | 1.59M shares 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |